Science that Strikes the Right Chord
Cabaletta Bio seeks to employ its Cabaletta Approach to B cell Ablation (CABA™) platform to develop T cell products to transform the lives of patients with autoimmune diseases by aiming to deliver deep and durable – potentially curative – responses.
How We Target Autoimmune Disease
A “cabaletta” is a rapid, repetitive, and technically challenging section of an operatic aria, designed to showcase the skills of the lead singer. Analogously, Cabaletta Bio strives to achieve rapid and repetitive product development, building on our indication prioritization and biologic platform that targets the driver of specific autoimmune diseases without the need for long-term immunosuppression.